LogiPharma Asia 2026 Benchmarking Report

Pharmaceutical supply chains are under unprecedented pressure. Global disruptions, regulatory complexity, and rising patient expectations have exposed the limits of traditional, cost-focused models. In this environment, digital transformation is no longer optional — it’s the difference between resilience and vulnerability.

The 2026 LogiPharma Asia Benchmarking Report gathers insights from over 100 senior pharma executives, revealing how industry leaders are advancing digital maturity, integrating ERP and AI, and redefining resilience across Asia’s pharmaceutical supply networks.